Soleus Capital Management, L.P.

Position in VCEL — Vericel Corp

CIK 1802630 GREENWICH, CT

Position in VCEL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$82,003,871

+$54,492,231 QoQ

Shares Held

2,549,079

+233.6% QoQ

Ownership

4.99%

of shares outstanding

% of Portfolio

3.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Soleus Capital Management, L.P. holds $1,422,770,178 across 59 Biotechnology names. VCEL ranks #5 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	1,153,087	$297,865,433
2	CELC	Celcuity Inc.	1,284,378	$146,598,904
3	TGTX	Tg Therapeutics, Inc.	4,029,319	$133,853,977
4	PRAX	Praxis Precision Medicines, Inc.	330,517	$106,489,272
5	VCEL	Vericel Corp This page	2,549,079	$82,003,871
6	GERN	Geron Corp	41,508,659	$61,847,901
7	IMUX	Immunic, Inc.	4,500,000	$49,950,000
8	EWTX	Edgewise Therapeutics, Inc.	1,449,915	$45,672,322

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$82,003,871	2,549,079	+233.6%	Shares	Sole	2026-05-14
2025-12-31	$27,511,640	764,000	+53.4%	Shares	Sole	2026-02-12
2025-09-30	$15,670,580	497,953	+877.3%	Shares	Sole	2025-11-14
2025-06-30	$2,168,050	50,953	-36.9%	Shares	Sole	2025-08-15
2024-12-31	$4,431,017	80,696	+20.4%	Shares	Sole	2025-02-14
2023-06-30	$2,519,030	67,049	-79.5%	Shares	Sole	2023-08-14
2023-03-31	$9,571,484	326,449	-64.1%	Shares	Sole	2023-05-15
2022-12-31	$23,942,980	908,997	+143.0%	Shares	Sole	2023-02-14
2022-09-30	$8,676,800	374,000	+58.1%	Shares	Sole	2022-11-14
2020-12-31	$7,305,868	236,589	-33.0%	Shares	Sole	2021-04-29
2020-09-30	$6,541,201	353,006	+48.0%	Shares	Sole	2020-11-13
2020-06-30	$3,296,512	238,532	-32.3%	Shares	Sole	2020-08-14
2020-03-31	$3,230,884	352,332	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.